skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 93,158  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Tumors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype
Material Type:
Article
Add to My Research

Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype

Molecular biology reports, 2024-12, Vol.51 (1), p.654-654 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature B.V. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2024. The Author(s), under exclusive licence to Springer Nature B.V. ;ISSN: 0301-4851 ;EISSN: 1573-4978 ;DOI: 10.1007/s11033-024-09602-6 ;PMID: 38735002

Digital Resources/Online E-Resources

2
miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review
Material Type:
Article
Add to My Research

miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review

Journal of Egyptian National Cancer Institute, 2024-12, Vol.36 (1), p.16-12 [Peer Reviewed Journal]

The Author(s) 2024 ;COPYRIGHT 2024 Springer ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1110-0362 ;EISSN: 2589-0409 ;DOI: 10.1186/s43046-024-00220-8

Full text available

3
The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study)
Material Type:
Article
Add to My Research

The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy in premenopausal women, diagnosed with uterine fibroids: protocol for a randomized controlled study (MyLacR study)

Current controlled trials in cardiovascular medicine, 2024-12, Vol.25 (1), p.343 [Peer Reviewed Journal]

The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-024-08170-1

Full text available

4
Promising predictive molecular biomarkers for cervical cancer (Review)
Material Type:
Article
Add to My Research

Promising predictive molecular biomarkers for cervical cancer (Review)

International journal of molecular medicine, 2024-06, Vol.53 (6)

Copyright Spandidos Publications UK Ltd. 2024 ;Copyright: © 2024 Lizano et al. 2024 ;ISSN: 1107-3756 ;EISSN: 1791-244X ;DOI: 10.3892/ijmm.2024.5374 ;PMID: 38606495

Full text available

5
Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses
Material Type:
Article
Add to My Research

Malignant ovarian and testicular germ cell tumors: Common characteristics but different prognoses

Journal of internal medicine, 2024-06, Vol.295 (6), p.715-734 [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Ltd on behalf of Association for Publication of The . ;2024 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. ;2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0954-6820 ;ISSN: 1365-2796 ;EISSN: 1365-2796 ;DOI: 10.1111/joim.13778 ;PMID: 38468475

Digital Resources/Online E-Resources

6
N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma
Material Type:
Article
Add to My Research

N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma

Clinical and experimental pharmacology & physiology, 2024-06, Vol.51 (6), p.e13864 [Peer Reviewed Journal]

2024 John Wiley & Sons Australia, Ltd. ;EISSN: 1440-1681 ;DOI: 10.1111/1440-1681.13864 ;PMID: 38679464

Digital Resources/Online E-Resources

7
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer
Material Type:
Article
Add to My Research

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

International journal of gynecological cancer, 2024-05, p.ijgc-2024-005522 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2024-005522

Digital Resources/Online E-Resources

8
Polycythemia vera and noncirrhotic portal hypertension diagnosed during pregnancy
Material Type:
Article
Add to My Research

Polycythemia vera and noncirrhotic portal hypertension diagnosed during pregnancy

Canadian Medical Association journal (CMAJ), 2024-05, Vol.196 (19), p.E657-E660 [Peer Reviewed Journal]

COPYRIGHT 2024 CMA Impact Inc. ;Copyright CMA Impact, Inc. May 21, 2024 ;2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.231170 ;PMID: 38772602

Full text available

9
Inpatient disease spectrum and clinical characteristics of surgical disorders in pediatric and adolescent gynecology: A single-institute study of 12 years data from China
Material Type:
Article
Add to My Research

Inpatient disease spectrum and clinical characteristics of surgical disorders in pediatric and adolescent gynecology: A single-institute study of 12 years data from China

Chinese medical journal, 2024-05, Vol.137 (10), p.1240-1242 [Peer Reviewed Journal]

Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2024 ;ISSN: 0366-6999 ;EISSN: 2542-5641 ;DOI: 10.1097/CM9.0000000000003086 ;PMID: 38595121

Full text available

10
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)
Material Type:
Article
Add to My Research

A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)

International journal of gynecological cancer, 2024-05, p.ijgc-2023-005200 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005200 ;PMID: 38760075

Digital Resources/Online E-Resources

11
Unveiling tumor invasiveness: enhancing cancer diagnosis with phase-contrast microtomography for 3D virtual histology
Material Type:
Article
Add to My Research

Unveiling tumor invasiveness: enhancing cancer diagnosis with phase-contrast microtomography for 3D virtual histology

European physical journal plus, 2024-05, Vol.139 (5), p.413 [Peer Reviewed Journal]

The Author(s) 2024 ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2190-5444 ;DOI: 10.1140/epjp/s13360-024-05188-x

Digital Resources/Online E-Resources

12
Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity
Material Type:
Article
Add to My Research

Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5384 [Peer Reviewed Journal]

2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25105384

Full text available

13
Cedars-Sinai Medical Center issued patent titled "Use of Anti-Il-6 Antibody, E.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (Abmr)"
Material Type:
Newsletter Article
Add to My Research

Cedars-Sinai Medical Center issued patent titled "Use of Anti-Il-6 Antibody, E.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (Abmr)"

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 14, 2024

Digital Resources/Online E-Resources

14
Reduction-sensitive polymeric carrier for the targeted delivery of a quinazoline derivative for enhanced generation of reactive oxygen species against cancer
Material Type:
Article
Add to My Research

Reduction-sensitive polymeric carrier for the targeted delivery of a quinazoline derivative for enhanced generation of reactive oxygen species against cancer

Biomaterials science, 2024-05, Vol.12 (10), p.2626 [Peer Reviewed Journal]

EISSN: 2047-4849 ;DOI: 10.1039/d3bm02136j ;PMID: 38526801

Digital Resources/Online E-Resources

15
Cedars-Sinai Medical Center issued patent titled "Use of Cancer Cell Expression of Cadherin 12 and Cadherin 18 to Treat Muscle Invasive and Metastatic Bladder Cancers"
Material Type:
Newsletter Article
Add to My Research

Cedars-Sinai Medical Center issued patent titled "Use of Cancer Cell Expression of Cadherin 12 and Cadherin 18 to Treat Muscle Invasive and Metastatic Bladder Cancers"

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 14, 2024

Digital Resources/Online E-Resources

16
WEEKLY RECAP: JOHNS HOPKINS MEDICINE INTERNATIONAL LLC NEWS THIS PAST WEEK MAY 12, 2024
Material Type:
Newsletter Article
Add to My Research

WEEKLY RECAP: JOHNS HOPKINS MEDICINE INTERNATIONAL LLC NEWS THIS PAST WEEK MAY 12, 2024

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 13, 2024

Digital Resources/Online E-Resources

17
Probing Genetics and Environmental Factors underlying Uterine Fibroid Tumorigenesis in Ghana, West Africa
Material Type:
Article
Add to My Research

Probing Genetics and Environmental Factors underlying Uterine Fibroid Tumorigenesis in Ghana, West Africa

Research Ideas and Outcomes, 2024-05, Vol.10, p.1-18 [Peer Reviewed Journal]

EISSN: 2367-7163 ;DOI: 10.3897/rio.10.e116907

Full text available

18
Prognostic value of molecular classification in stage IV endometrial cancer
Material Type:
Article
Add to My Research

Prognostic value of molecular classification in stage IV endometrial cancer

International journal of gynecological cancer, 2024-05, p.ijgc-2023-005058 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005058 ;PMID: 38658021

Digital Resources/Online E-Resources

19
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)
Material Type:
Article
Add to My Research

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)

International journal of gynecological cancer, 2024-05, p.ijgc-2023-005229 [Peer Reviewed Journal]

IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-005229 ;PMID: 38724237

Digital Resources/Online E-Resources

20
WEEKLY RECAP: JOHNS HOPKINS MEDICINE INTERNATIONAL LLC NEWS THIS PAST WEEK MAY 08, 2024
Material Type:
Newsletter Article
Add to My Research

WEEKLY RECAP: JOHNS HOPKINS MEDICINE INTERNATIONAL LLC NEWS THIS PAST WEEK MAY 08, 2024

News Bites - Private Companies, 2024

Copyright News Bites Pty Ltd May 9, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 93,158  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1965  (31)
  2. 1965 To 1979  (51)
  3. 1980 To 1993  (14,015)
  4. 1994 To 2008  (43,878)
  5. After 2008  (35,204)
  6. More options open sub menu

Language 

  1. English  (93,095)
  2. Japanese  (13,768)
  3. German  (93)
  4. Polish  (47)
  5. Portuguese  (34)
  6. French  (26)
  7. Turkish  (17)
  8. Norwegian  (11)
  9. Chinese  (8)
  10. Spanish  (5)
  11. Russian  (3)
  12. Ukrainian  (3)
  13. Italian  (2)
  14. Romanian  (1)
  15. Latin  (1)
  16. Korean  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait